AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
CLASSIFICATION AND EPIDEMIOLOGY OF SCLERODERMA
Authors: MAYES MD
Citation: Md. Mayes, CLASSIFICATION AND EPIDEMIOLOGY OF SCLERODERMA, Seminars in cutaneous medicine and surgery, 17(1), 1998, pp. 22-26
MATERNAL SCLERODERMA - PLACENTAL FINDINGS AND PERINATAL OUTCOME
Authors: DOSS BJ JACQUES SM ATTY S MAYES MD QURESHI F
Citation: Bj. Doss et al., MATERNAL SCLERODERMA - PLACENTAL FINDINGS AND PERINATAL OUTCOME, Modern pathology, 11(1), 1998, pp. 103-103
SAFETY AND PHARMACOKINETICS OF RECOMBINANT HUMAN RELAXIN IN SYSTEMIC-SCLEROSIS
Authors: SEIBOLD JR CLEMENTS PJ FURST DE MAYES MD MCCLOSKEY DA MORELAND LW WHITE B WIGLEY FM ROCCO S ERIKSON M HANNIGAN JF SANDERS ME AMENTO EP
Citation: Jr. Seibold et al., SAFETY AND PHARMACOKINETICS OF RECOMBINANT HUMAN RELAXIN IN SYSTEMIC-SCLEROSIS, Journal of rheumatology, 25(2), 1998, pp. 302-307
THE USE OF INDWELLING VENOUS CATHETERS IN PATIENTS WITH SYSTEMIC-SCLEROSIS (SSC)
Authors: INJIC Z MAYES MD
Citation: Z. Injic et Md. Mayes, THE USE OF INDWELLING VENOUS CATHETERS IN PATIENTS WITH SYSTEMIC-SCLEROSIS (SSC), Arthritis and rheumatism, 41(9), 1998, pp. 902-902
SELF-REPORTED MEDICAL HISTORY AND MEDICATION USE AMONG WOMEN WITH UNDIFFERENTIATED CONNECTIVE-TISSUE DISEASE
Authors: LACEY JV MAYES MD LAING TJ GILLESPIE BW GARABRANT DH SCHOTTERFEID D
Citation: Jv. Lacey et al., SELF-REPORTED MEDICAL HISTORY AND MEDICATION USE AMONG WOMEN WITH UNDIFFERENTIATED CONNECTIVE-TISSUE DISEASE, Arthritis and rheumatism, 41(9), 1998, pp. 1821-1821
SELF-REPORTED EXPOSURE TO PESTICIDES AND HERBICIDES AS RISK-FACTORS FOR UNDIFFERENTIATED CONNECTIVE-TISSUE DISEASE (UCTD)
Authors: LACEY JV GARABRANT DH MAYES MD LAING TJ GILLESPIE BW SCHOTTENFELD D
Citation: Jv. Lacey et al., SELF-REPORTED EXPOSURE TO PESTICIDES AND HERBICIDES AS RISK-FACTORS FOR UNDIFFERENTIATED CONNECTIVE-TISSUE DISEASE (UCTD), Arthritis and rheumatism, 41(9), 1998, pp. 1822-1822
ORAL ILOPROST TREATMENT IN PATIENTS WITH RAYNAUDS-PHENOMENON SECONDARY TO SYSTEMIC-SCLEROSIS - A MULTICENTER, PLACEBO-CONTROLLED DOUBLE-BLIND STUDY
Authors: WIGLEY FM KORN JH CSUKA ME MEDSGER TA ROTHFIELD NF ELLMAN M MARTIN R COLLIER DH WEINSTEIN A FURST DE JIMENEZ SA MAYES MD MERKEL PA GRUBER B KAUFMAN L VARGA J BELL P KERN J MARROTT P WHITE B SIMMS RW PHILLIPS AC SEIBOLD JR
Citation: Fm. Wigley et al., ORAL ILOPROST TREATMENT IN PATIENTS WITH RAYNAUDS-PHENOMENON SECONDARY TO SYSTEMIC-SCLEROSIS - A MULTICENTER, PLACEBO-CONTROLLED DOUBLE-BLIND STUDY, Arthritis and rheumatism, 41(4), 1998, pp. 670-677
REPRODUCTIVE HISTORY, ORAL-CONTRACEPTIVE USE, ESTROGEN REPLACEMENT THERAPY AND THE RISK OF DEVELOPING SCLERODERMA
Authors: BEEBE JL LACEY JV MAYES MD GILLESPIE BW COOPER BC LAING TJ SCHOTTENFELD D
Citation: Jl. Beebe et al., REPRODUCTIVE HISTORY, ORAL-CONTRACEPTIVE USE, ESTROGEN REPLACEMENT THERAPY AND THE RISK OF DEVELOPING SCLERODERMA, Arthritis and rheumatism, 40(9), 1997, pp. 419-419
REPRODUCTIVE HISTORY, ORAL-CONTRACEPTIVE USE, AND ESTROGEN REPLACEMENT THERAPY IN WOMEN WITH UNDIFFERENTIATED CONNECTIVE-TISSUE DISEASE (UCTD)
Authors: LACEY JV BEEBE JL MAYES MD GILLESPIE BW LAING TJ COOPER BC
Citation: Jv. Lacey et al., REPRODUCTIVE HISTORY, ORAL-CONTRACEPTIVE USE, AND ESTROGEN REPLACEMENT THERAPY IN WOMEN WITH UNDIFFERENTIATED CONNECTIVE-TISSUE DISEASE (UCTD), Arthritis and rheumatism, 40(9), 1997, pp. 530-530
CONTROLLED TRIAL OF RECOMBINANT HUMAN RELAXIN (RHRLXN) IN DIFFUSE SCLERODERMA (DS)
Authors: SEIBOLD JR KORN J SIMMS R CLEMENTS PJ MORELAND L MAYES MD FURST DE ROTHFIELD N STEEN V WEISMAN M DEMARCO P COLLIER D WIGLEY F MERKEL PA CSUKA ME ROCCO S ERIKSON M HANNIGAN J HARKONEN WS SANDERS ME
Citation: Jr. Seibold et al., CONTROLLED TRIAL OF RECOMBINANT HUMAN RELAXIN (RHRLXN) IN DIFFUSE SCLERODERMA (DS), Arthritis and rheumatism, 40(9), 1997, pp. 557-557
SELF-REPORTED EXPOSURE TO SOLVENTS IN WOMEN WITH SYSTEMIC-SCLEROSIS (SSC)
Authors: LACEY JV GARABRANT DH GILLESPIE BW COOPER BC LAING TJ MAYES MD SCHOTTENFELD D
Citation: Jv. Lacey et al., SELF-REPORTED EXPOSURE TO SOLVENTS IN WOMEN WITH SYSTEMIC-SCLEROSIS (SSC), Arthritis and rheumatism, 40(9), 1997, pp. 1021-1021
SELF-REPORTED EXPOSURE TO SOLVENTS IN WOMEN WITH UNDIFFERENTIATED CONNECTIVE-TISSUE DISEASE (UCTD)
Authors: LACEY JV GARABRANT DH GILLESPIE W COOPER BC LAING TJ MAYES MD SCHOTTENFELD D
Citation: Jv. Lacey et al., SELF-REPORTED EXPOSURE TO SOLVENTS IN WOMEN WITH UNDIFFERENTIATED CONNECTIVE-TISSUE DISEASE (UCTD), Arthritis and rheumatism, 40(9), 1997, pp. 1022-1022
CONNECTIVE-TISSUE DISEASE REGISTRIES
Authors: MAYES MD GIANNINI EH PACHMAN LM BUYON JP FLECKMAN P
Citation: Md. Mayes et al., CONNECTIVE-TISSUE DISEASE REGISTRIES, Arthritis and rheumatism, 40(9), 1997, pp. 1556-1559
RACIAL-DIFFERENCES IN SCLERODERMA AMONG WOMEN IN MICHIGAN
Authors: LAING TJ GILLESPIE BW TOTH MB MAYES MD GALLAVAN RH BURNS CJ JOHANNS JR COOPER BC KEROACK BJ WASKO MCM LACEY JV SCHOTTENFELD D
Citation: Tj. Laing et al., RACIAL-DIFFERENCES IN SCLERODERMA AMONG WOMEN IN MICHIGAN, Arthritis and rheumatism, 40(4), 1997, pp. 734-742
SCLERODERMA EPIDEMIOLOGY
Authors: MAYES MD
Citation: Md. Mayes, SCLERODERMA EPIDEMIOLOGY, Rheumatic diseases clinics of North America, 22(4), 1996, pp. 751
THE EPIDEMIOLOGY OF SCLERODERMA AMONG WOMEN - ASSESSMENT OF RISK FROMEXPOSURE TO SILICONE AND SILICA
Authors: BURNS CJ LAING TJ GILLESPIE BW HEERINGA SG ALCSER KH MAYES MD WASKO MCM COOPER BC GARABRANT DH SCHOTTENFELD D
Citation: Cj. Burns et al., THE EPIDEMIOLOGY OF SCLERODERMA AMONG WOMEN - ASSESSMENT OF RISK FROMEXPOSURE TO SILICONE AND SILICA, Journal of rheumatology, 23(11), 1996, pp. 1904-1911
THE EFFECT ON MEMORY OF CHRONIC PREDNISONE TREATMENT IN PATIENTS WITHSYSTEMIC-DISEASE
Authors: KEENAN PA JACOBSON MW SOLEYMANI RM MAYES MD STRESS ME YALDOO DT
Citation: Pa. Keenan et al., THE EFFECT ON MEMORY OF CHRONIC PREDNISONE TREATMENT IN PATIENTS WITHSYSTEMIC-DISEASE, Neurology, 47(6), 1996, pp. 1396-1402
PREVALENCE, INCIDENCE AND SURVIVAL RATES OF SYSTEMIC-SCLEROSIS THE DETROIT METROPOLITAN-AREA
Authors: MAYES MD LAING TJ GILLESPIE W COOPER BC LACEY JV HIRSCHENBERGER WS ATTY SM SCHOTTENFELD D
Citation: Md. Mayes et al., PREVALENCE, INCIDENCE AND SURVIVAL RATES OF SYSTEMIC-SCLEROSIS THE DETROIT METROPOLITAN-AREA, Arthritis and rheumatism, 39(9), 1996, pp. 737-737
THE ASSOCIATION BETWEEN SILICONE EXPOSURE AND UNDIFFERENTIATED CONNECTIVE-TISSUE DISEASE AMONG WOMEN IN MICHIGAN AND OHIO
Authors: LAING TJ GILLESPIE BW LACEY JV GARABRANT DH COOPER BC HEERINGA SG ALCSER KH CHO SW MAYES MD SCHOTTENFELD D
Citation: Tj. Laing et al., THE ASSOCIATION BETWEEN SILICONE EXPOSURE AND UNDIFFERENTIATED CONNECTIVE-TISSUE DISEASE AMONG WOMEN IN MICHIGAN AND OHIO, Arthritis and rheumatism, 39(9), 1996, pp. 740-740
FAMILIAL AGGREGATION OF PRIMARY RAYNAUDS-DISEASE
Authors: FREEDMAN RR MAYES MD
Citation: Rr. Freedman et Md. Mayes, FAMILIAL AGGREGATION OF PRIMARY RAYNAUDS-DISEASE, Arthritis and rheumatism, 39(7), 1996, pp. 1189-1191
THE DESIGN OF A POPULATION-BASED CASE-CONTROL STUDY OF SYSTEMIC-SCLEROSIS (SCLERODERMA) - COMMENTARY ON THE UNIVERSITY-OF-MICHIGAN STUDY
Authors: SCHOTTENFELD D BURNS CJ GILLESPIE BW LAING TJ MAYES MD HEERINGA SG ALCSER KH
Citation: D. Schottenfeld et al., THE DESIGN OF A POPULATION-BASED CASE-CONTROL STUDY OF SYSTEMIC-SCLEROSIS (SCLERODERMA) - COMMENTARY ON THE UNIVERSITY-OF-MICHIGAN STUDY, Journal of clinical epidemiology, 48(4), 1995, pp. 583-586
MYOFIBROBLASTS FROM SCLERODERMA SKIN SYNTHESIZE ELEVATED LEVELS OF COLLAGEN AND TISSUE INHIBITOR OF METALLOPROTEINASE (TIMP-1) WITH 2 FORMSOF TIMP-1
Authors: KIRK TZ MARK ME CHUA CC CHUA BH MAYES MD
Citation: Tz. Kirk et al., MYOFIBROBLASTS FROM SCLERODERMA SKIN SYNTHESIZE ELEVATED LEVELS OF COLLAGEN AND TISSUE INHIBITOR OF METALLOPROTEINASE (TIMP-1) WITH 2 FORMSOF TIMP-1, The Journal of biological chemistry, 270(7), 1995, pp. 3423-3428
BLOCKADE OF VASOSPASTIC ATTACKS BY ALPHA(2)-ADRENERGIC BUT NOT ALPHA(1)-ADRENERGIC ANTAGONISTS IN IDIOPATHIC RAYNAUDS-DISEASE
Authors: FREEDMAN RR BAER RP MAYES MD
Citation: Rr. Freedman et al., BLOCKADE OF VASOSPASTIC ATTACKS BY ALPHA(2)-ADRENERGIC BUT NOT ALPHA(1)-ADRENERGIC ANTAGONISTS IN IDIOPATHIC RAYNAUDS-DISEASE, Circulation, 92(6), 1995, pp. 1448-1451
INTRAVENOUS PULSE CYCLOPHOSPHAMIDE TREATMENT FOR SLE AND THE RISK OF MALIGNANCY
Authors: MAYES MD WOOLEY P MOSLEY A DHAR P INJIC Z SEGAL B BRICKMAN C SEVERSON R
Citation: Md. Mayes et al., INTRAVENOUS PULSE CYCLOPHOSPHAMIDE TREATMENT FOR SLE AND THE RISK OF MALIGNANCY, Arthritis and rheumatism, 38(9), 1995, pp. 906-906
DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER TRIAL USING CHIMERIC MONOCLONAL ANTI-CD4 ANTIBODY, CM-T412, IN RHEUMATOID-ARTHRITIS PATIENTS RECEIVING CONCOMITANT METHOTREXATE
Authors: MORELAND LW PRATT PW MAYES MD POSTLETHWAITE A WEISMAN MH SCHNITZER T LIGHTFOOT R CALABRESE L ZELINGER DJ WOODY JN KOOPMAN WJ
Citation: Lw. Moreland et al., DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER TRIAL USING CHIMERIC MONOCLONAL ANTI-CD4 ANTIBODY, CM-T412, IN RHEUMATOID-ARTHRITIS PATIENTS RECEIVING CONCOMITANT METHOTREXATE, Arthritis and rheumatism, 38(11), 1995, pp. 1581-1588
Risultati: 1-25 | 26-31